The SPRI feasibility team will begin by evaluating our established site relationships, assessing each one based on previous performance (quality and quantity), patient population, and interest. Clinicians know our team values their insight and have been generous in providing open and honest dialogue regarding the proposed trial design (i.e. does it fit within their site setting and within the regulatory environment of the area; will their patients be willing to participate).

Considerations Include:

  • Clinician’s level of experience
  • Investigator interest
  • Patient population
  • Enrollment history